有机化学人才网 | 最新人才 | 最新职位 | 技术交易 | 药物合成 |
   
全站搜索: |
  您当前位置:网站首页 >> 药物合成路线图解
 

药物详细合成路线

Name alpha-Tocopherol;alpha-Tocoferol;Vitamin E
Chemical Name 2(R),5,7,8-Tetramethyl-2-[4(R),8(R),12-trimethyltridecyl]-3,4-dihydro-2H-1-benzopyran-6-ol
CAS 59-02-9
Related CAS
Formula C29H50O2
Structure
Formula Weight 430.72065
Stage 未确定
Company
Activity/Mechanism  
Syn. Route 3
Route 1
the intermediate triphenylphosphonium salt (xxi) has been obtained as follows: the reformatsky condensation of 4-methoxybenzaldehyde (i) with methyl 2-bromopropionate (ii) gives a mixture of the syn and anti hydroxyesters (iii) and (iv). the syn isomer (iii) was dehydrated by means of msoh yielding the unsaturated ester (v), which is reduced with lialh4 to the unsaturated alcohol (vi). the hydroboration of (vi) affords the diol (rac)-anti-(vii), which is also obtained by direct reduction of the anti-hydroxyester (iv) with lialh4. the optical resolution of (rac)-(vii) with lipase amano p and vinyl acetate affords the chiral monoacetate (2r,3r)-(viii), which is fully acetylated with ac2o giving the diacetate (ix). selective catalytic hydrogenolysis of (ix) with h2 over pd/c in methanol yields the primary monoacetate (x), which is hydrolyzed with k2co3 in methanol to affords the primary alcohol (xi). the reaction of (xi) with cbr4 and pph3 in thf provides the bromide (xii), which by treatment with sodium phenylsulfinate (a) affords the phenylsulfone (xiii). ozonolysis of (xiii) with o3, followed by oxidation with h2o2 gives the carboxylic acid (xiv), which is methylated with diazomethane to the ester (xv). the reduction of (xv) with libh4 in thf yields the alcohol (xvi), which is protected with dhp and ppts yielding the tetrahydropyranyl ether (xvii). the condensation of sulfone (xvii) with the iodoalkane (xviii) by means of lda, followed by treatment with hcl in ethanol affords the intermediate addition compound (xix), which by elimination of the thp group provides the alcohol (xx). finally, the reaction of (xx) with cbr4 and pph3 affords the target intermediate phosphonium salt (xxi).
List of intermediates No.
methyl 2-phenoxyacetate (i)
1,3-dihydroxybenzo[b]acridin-12(5h)-one (ii)
1,4-dioxaspiro[4.5]decan-8-ol (iii)
4-chloro-7-(1,4-dioxaspiro[4.5]dec-8-yl)-5-iodo-7h-pyrrolo[2,3-d]pyrimidine (iv)
tert-butyl 4-[4-chloro-7-(1,4-dioxaspiro[4.5]dec-8-yl)-7h-pyrrolo[2,3-d]pyrimidin-5-yl]-2-fluorophenylcarbamate (v)
5-(4-amino-3-fluorophenyl)-7-(1,4-dioxaspiro[4.5]dec-8-yl)-7h-pyrrolo[2,3-d]pyrimidin-4-amine; 4-[4-amino-7-(1,4-dioxaspiro[4.5]dec-8-yl)-7h-pyrrolo[2,3-d]pyrimidin-5-yl]-2-fluorophenylamine (vi)
4-[4-amino-5-(4-amino-3-fluorophenyl)-7h-pyrrolo[2,3-d]pyrimidin-7-yl]cyclohexanone (rac-vii)
5-(4-amino-3-fluorophenyl)-7-[4-(4-methyl-1-piperazinyl)cyclohexyl]-7h-pyrrolo[2,3-d]pyrimidin-4-amine; 5-(4-amino-3-fluorophenyl)-7-[4-(4-methyl-1-piperazinyl)cyclohexyl]-7h-pyrrolo[2,3-d]pyrimidin-4-ylamine (2r)
2,3-dichlorobenzenesulfonyl chloride (3r-viii)
benzyl (1s)-1-{[((1s)-4-[(aminocarbonyl)amino]-1-{[4-(hydroxymethyl)anilino]carbonyl}butyl)amino]carbonyl}-2-methylpropylcarbamate (ix)
6-(3-methyl-1,4-dioxo-1,4-dihydro-2-naphthalenyl)hexanoic acid (x)
2-amino-4-[(3s)-3-(dimethylamino)pyrrolidinyl]phenylamine; 4-[(3s)-3-(dimethylamino)pyrrolidinyl]-1,2-benzenediamine (xi)
ethyl 2-{5-[(3s)-3-(dimethylamino)pyrrolidinyl]-1h-benzimidazol-2-yl}acetate (xii)
(2r,3s,4r,5r)-2-(hydroxymethyl)-5-{6-[(3r)tetrahydro-3-furanylamino]-9h-purin-9-yl}tetrahydro-3,4-furandiol (a)
((3ar,4r,6r,6as)-2,2-dimethyl-6-{6-[(3r)tetrahydro-3-furanylamino]-9h-purin-9-yl}tetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methanol (xiii)
((3ar,4r,6r,6as)-2,2-dimethyl-6-{6-[(3r)tetrahydro-3-furanylamino]-9h-purin-9-yl}tetrahydrofuro[3,4-d][1,3]dioxol-4-yl)methyl methylcarbamate (xiv)
(3r)tetrahydro-3-furanamine; (3r)tetrahydro-3-furanylamine (xv)
2-hydroxy-2-(3-pyridinyl)acetonitrile (xvi)
tetraethylene glycol; tetraglycol (xvii)
3-[4-(2-{2-[2-(2-{[4-(3-pyridinyl)-1,2,5-thiadiazol-3-yl]oxy}ethoxy)ethoxy]ethoxy}ethoxy)-1,2,5-thiadiazol-3-yl]pyridine; 4-(3-pyridinyl)-1,2,5-thiadiazol-3-yl 2-{2-[2-(2-{[4-(3-pyridinyl)-1,2,5-thiadiazol-3-yl]oxy}ethoxy)ethoxy]ethoxy}ethyl ether (xviii)
Reference 1:
    nozawa, m.; et al.; enantioselective synthesis of (2r,4r,8r)-alpha-tocopherol (vitamin e) based on enzymatic function. chem pharm bull 2000, 48, 2, 272.

Route 2
the esterification of (rac)-6-hydroxy-2,5,7,8-tetramethyl-3,4-dihydro-2h-1-benzopyran-2-carboxylic acid (xxii) with diazomethane gives the methyl ester (xxiii), which is treated with bn-br and k2co3 yielding the benzyl ether (xxiv). the reduction of the ester group of (xxiv) with lialh4 provides the carbinol (xxv), which is debenzylated with h2 over pd/c to afford the racemic phenol (rac)-(xxvi). optical resolution of (xxvi) by means of lipase pl-266 and vinyl acetate gives the chiral acetate (s)-(xxvii), which is rebenzylated with bnbr yielding the benzyl ether (xxviii). the deacetylation of (xxviii) with lialh4 in ethyl ether affords the carbinol (xxix), which is oxidized with oxalyl chloride to the aldehyde (xxx). the condensation of (xxx) with the intermediate phosphonium salt (xxi) by means of n-buli in thf gives the olefin (xxxi), which is finally hydrogenated and debenzylated with h2 over pd/c in ethyl acetate.
List of intermediates No.
3-(5-oxo-2-pyrrolidinyl)propionic acid (xxv)
(2-benzyl-1-benzofuran-3-yl)(4-methoxyphenyl)methanone (xxii)
4-naphtho[2,3-b][1]benzofuran-11-ylphenol (xxvi)
n-(2-chloroethyl)-n-(4-pyridinyl)urea (xxi)
1-(4-pyridinyl)-2-imidazolidinone (xxiii)
4-[(5-bromopentyl)oxy]-1,1-biphenyl; [1,1-biphenyl]-4-yl 5-bromopentyl ether (xxiv)
5-{2-[(4as,4br,5s,6as,9ar,10as,10bs)-4b-fluoro-5-hydroxy-4a,6a,8,8-tetramethyl-2-oxo-2,4a,4b,5,6,6a,9a,10,10a,10b,11,12-dodecahydro-6bh-naphtho[2,1:4,5]indeno[1,2-d][1,3]dioxol-6-yl]-2-oxoethoxy}-5-oxopentanoic acid (xxvii)
[(1as,8s,8ar,8bs)-6-amino-8a-methoxy-5-methyl-4,7-dioxo-1,1a,2,4,7,8,8a,8b-octahydroazireno[2,3:3,4]pyrrolo[1,2-a]indol-8-yl]methyl carbamate (xxviii)
2-nitro-p-phenetidine; 4-amino-3-nitrophenetole; 4-ethoxy-2-nitroaniline; 4-ethoxy-2-nitrobenzeneamine (xxix)
1-hydroxyhydrindene; 1-hydroxyindan; 1-indanol (xxx)
1-bromoindane (xxxi)
Reference 1:
    nozawa, m.; et al.; enantioselective synthesis of (2r,4r,8r)-alpha-tocopherol (vitamin e) based on enzymatic function. chem pharm bull 2000, 48, 2, 272.

Route 3
the chlorination of myrcene (i) with cl2 in refluxing pentane gives the choromyrcene (ii), and the hydrochlorination of (i) catalyzed by cucl yields a mixture of geranyl/neryl chloride (iii). the reductive coupling of (ii) and (iii) by means of mg and cucl affords beta-springene (iv), which is condensed with 2,3,6-trimethylhydroquinone (v) by means of cyclooctadienyl rhodium chloride dimer [rhcl(cod)]2 and k2co3 in refluxing toluene to provide the adduct (vi). the cyclization of (vi) by means of mealcl2 of ts-oh in refluxing hexane furnishes the tocotrienol (vii), which is finally hydrogenated with h2 over pd/c in ethanol to give the target (rac)-vitamin e.
List of intermediates No.
benzyl (1r)-2-(benzylamino)-1-(methoxymethyl)-2-oxoethylcarbamate (v)
3-chloro-2-hydroxy-3-[4-(3-methyl-2-thienyl)phenyl]butanenitrile (i)
(z)-1-cyano-2-[4-(3-methyl-2-thienyl)phenyl]-1-propenyl acetate (ii)
(z)-2-ethoxy-3-[4-(3-methyl-2-thienyl)phenyl]-2-butenenitrile (iii)
3-[4-(3-methyl-2-thienyl)phenyl]-2-oxobutanenitrile (iv)
methyl (e)-2-cyano-3-[4-(3-methyl-2-thienyl)phenyl]-2-butenoate (vi)
methyl 2-(aminocarbonyl)-3-methyl-3-[4-(3-methyl-2-thienyl)phenyl]-2-oxiranecarboxylate (vii)
Reference 1:
    bienayme, h.; et al.; rhodium(i)-catalyzed addition of phenols to dienes. a new convergent synthesis of vitamin e. tetrahedron lett 2000, 41, 18, 3339.

来源:药化网

作者:药化小编

摘要:本文合成路线介绍的是药物中文名天然维生素 E;英文名alpha-Tocopherol;alpha-Tocoferol;Vitamin E;CAS[59-02-9]

 
推荐VIP企业
无锡景耀生物科技有限公司
杭州卢普生物科技有限公司
宁波赛伦化工有限公司
苏州昊赛生物科技有限公司
北京嘉盛扬医药科技有限公司
上海泽涵生物医药科技有限公司
河北固安三利化工公司
郑州凯普瑞生物技术有限公司
上海药谷药业有限公司
兰州康寓信生物科技有限公司
湖北朗昕生化药业有限公司
武汉福鑫化工有限公司
嘉兴市英南化工有限公司
苏州迪飞医药科技有限公司
北京富安凯科技有限公司
上海盛中医药化工有限公司
连云港天和化学有限公司
南京晨瑞医药科技有限公司
南京苏如化工有限公司
常州瑞盛化工有限公司
热门文章
华东地区丁二烯市场行情下行
江苏地区丙酮市场弱势下滑
国内甲苯主流出厂价格暂稳
山东地区三氯甲烷价格
江苏地区正丁醇市场最新动态
华南地区醋酸价格稳定
新型杀线虫剂三氟杀线酯成功研发
派姆单抗获 FDA 批准用于原
SDHI类杀菌剂中的潜力股——
啶酰菌胺原药产品登记企业达到2
鲁西地区三氯甲烷企业报价稳定
山东地区丙烷市场行情上涨
燕山周边苯酚市场走势暂稳
山东地区苯酚市场市场暂稳
国内原药市场表现强劲,农药原药
罗氏启动阿尔茨海默病候选药物
华东地区醋酸市场整体稳定
华北地区丁二烯市场维持盘整
山东地区苯酚市场市场稳定
华东地区BDO市场坚挺整理
 友情链接
有机化学人才网  
首页 | 广告服务 | 建站服务 | 关于我们 | 联系我们 | 版权声明